Eli Lilly and Co P/B Ratio
Data as of August 04, 2026
P/B Ratio
39.93
Stock Price
$1121.36
Book Value/Share
$28.09
Sector
Pharmaceuticals
How It's Calculated
39.93 = $1121.36 ÷ $28.09
What This Means
Eli Lilly and Co's P/B ratio of 39.93 is above 6. Asset-light business models and unrecognized intangible assets can make book value a limited denominator; the multiple alone does not determine fair value.
About Eli Lilly and Co
Eli Lilly and Co (LLY) operates in the Pharmaceuticals sector, specifically in Pharmaceuticals. With a market capitalization of about $1.08T, it ranks as a mega-cap stock — one of the largest publicly traded companies.
Shares recently traded near $1121.36, within a 52-week range of $623.78 to $1249.45 (-10.3% from the high, +79.8% from the low). Beta of 0.51 indicates relatively lower volatility versus the market.
Trailing profit margin is about 35.0%, signaling a strong profit margin relative to many peers.
Understanding This Metric
The price-to-book ratio compares market price to net asset value per share. For Eli Lilly and Co, P/B is especially useful when earnings are volatile or temporarily depressed. In Pharmaceuticals, asset-heavy business models often anchor closer to book value, while asset-light models may trade far above book.
Sector Comparison
Among Pharmaceuticals names on our S&P 100 coverage, Eli Lilly and Co's P/B ratio of 39.93 can be compared with peers such as JNJ (7.51), MRK (6.01), PFE (1.65). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Pharmaceuticals stocks.
Key Takeaways
- LLY is grouped in the Pharmaceuticals sector for peer comparisons.
- Recent beta of 0.51 suggests lower-than-market price sensitivity.
- Trailing profit margin of 35.0% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for LLY.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Other LLY Metrics
Frequently Asked Questions
What does LLY's price-to-book ratio indicate?
P/B compares share price to book value per share. Eli Lilly and Co's P/B of 39.93 reflects how the market prices net assets — especially relevant for asset-heavy Pharmaceuticals business models.
Is 39.93 above or below book value?
A P/B above 1.0 (39.93) means the market values LLY above accounting book value — often due to brands, growth, or intangible assets.
How does P/B compare within Pharmaceuticals?
Peer P/B levels in Pharmaceuticals (e.g. JNJ (7.51), BMY (7.13), MRK (6.01)) provide context; asset-light vs asset-heavy models differ materially.
Calculate the p/b ratio for any stock with our free calculator.
Open P/B Ratio Calculator →